Università degli Studi di Milano - Bicocca;Université de Genève;Université Claude Bernard Lyon 1
发明人:
申请号：
EP12167755.3
公开号：
EP2662372A1
申请日:
2012.05.11
申请国别(地区):
EP
年份:
2013
代理人:
摘要：
The present invention relates to inhibitors of the oncogenic protein kinase ALK of formula (I) as herein described and pharmaceutical compositions thereof, as well as to key intermediates towards their synthesis. The compounds of formula (I) are useful in the preparation of a medicament, in particular for the treatment of cancer.
